$ASRT has been mentioned 3 times over the past 12 months by 2 distinct FinTwit voices, with the first mention appearing on March 27, 2026. The most-active voice discussing the ticker is @ssi_invest (Special Situation Investments), which posted 2 mentions, while @microcapclub contributed 1 mention. Discussion of $ASRT centers on its merger situation with Garda Therapeutics, involving an $18.00 per share cash offer plus a non-tradeable CVR tied to Sprix®, with a 20-day go-shop period and tender offer requiring simple majority shareholder approval. The most recent mention occurred on April 27, 2026, noting that Garda was set to commence its tender offer on April 29, 2026, following expiration of the window-shop period.